Skin-Derived Dendritic Cells Induce Potent CD8+ T Cell Immunity in Recombinant Lentivector-Mediated Genetic Immunization

Immunity

Volumn 24, Issue 5, 2006, Pages 643-656

  He, Yukai ^a   Zhang, Jiying ^a   Donahue, Cara ^a   Falo Jr , Louis D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO

Indexed keywords

LENTIVIRUS VECTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; T LYMPHOCYTE ACTIVATION; VIRUS RECOMBINANT; ANIMAL; BIOLISTIC TRANSFORMATION; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; FLOW CYTOMETRY; GENE VECTOR; GENETICS; IMMUNOLOGY; LENTIVIRINAE; LYMPHOCYTE ACTIVATION; METHODOLOGY; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; ANTIGEN PRESENTATION; BIOLISTICS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC VECTORS; IMMUNIZATION; LENTIVIRUS; LENTIVIRUS INFECTIONS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TRANSFECTION;

EID: 33745609027     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.03.014     Document Type: Article

References (64)

1. Ada G., and Ramshaw I. DNA vaccination. Expert Opin. Emerg. Drugs 8 (2003) 27-35
2. Allan R.S., Smith C.M., Belz G.T., van Lint A.L., Wakim L.M., Heath W.R., and Carbone F.R. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301 (2003) 1925-1928
3. Anjuere F., Martinez del Hoyo G., Martin P., and Ardavin C. Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation. J. Leukoc. Biol. 67 (2000) 206-209
4. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
5. Barchet W., Oehen S., Klenerman P., Wodarz D., Bocharov G., Lloyd A.L., Nowak M.A., Hengartner H., Zinkernagel R.M., and Ehl S. Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur. J. Immunol. 30 (2000) 1356-1363
6. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., Howe B.J., and Dubin G. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351 (2004) 2286-2294
7. Belz G.T., Smith C.M., Eichner D., Shortman K., Karupiah G., Carbone F.R., and Heath W.R. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172 (2004) 1996-2000
8. Belz G.T., Shortman K., Bevan M.J., and Heath W.R. CD8{alpha}+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175 (2005) 196-200
9. Bennett C.L., van Rijn E., Jung S., Inaba K., Steinman R.M., Kapsenberg M.L., and Clausen B.E. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169 (2005) 569-576
10. Bosnjak L., Miranda-Saksena M., Koelle D.M., Boadle R.A., Jones C.A., and Cunningham A.L. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174 (2005) 2220-2227
11. Bousso P., and Robey E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4 (2003) 579-585
12. Breckpot K., Dullaers M., Bonehill A., van Meirvenne S., Heirman C., de Greef C., van der Bruggen P., and Thielemans K. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J. Gene Med. 5 (2003) 654-667
13. Carbone F.R., Belz G.T., and Heath W.R. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol. 25 (2004) 655-658
14. Celluzzi C.M., and Falo Jr. L.D. Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. J. Invest. Dermatol. 108 (1997) 716-720
15. Celluzzi C.M., and Falo Jr. L.D. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160 (1998) 3081-3085
16. Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., and Falo Jr. L.D. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183 (1996) 283-287
17. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo Jr. L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2 (1996) 1122-1128
18. den Haan J.M., Lehar S.M., and Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192 (2000) 1685-1696
19. Douillard P., Stoitzner P., Tripp C.H., Clair-Moninot V., Ait-Yahia S., McLellan A.D., Eggert A., Romani N., and Saeland S. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125 (2005) 983-994
20. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., and Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163 (1999) 6762-6768
21. Esslinger C., Romero P., and MacDonald H.R. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum. Gene Ther. 13 (2002) 1091-1100
22. Esslinger C., Chapatte L., Finke D., Miconnet I., Guillaume P., Levy F., and MacDonald H.R. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J. Clin. Invest. 111 (2003) 1673-1681
23. Glenn G.M., Kenney R.T., Ellingsworth L.R., Frech S.A., Hammond S.A., and Zoeteweij J.P. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev. Vaccines 2 (2003) 253-267
24. Green I., Stingl G., Shevach E.M., and Katz S.I. Antigen presentation and allogeneic stimulation by Langerhans cells. J. Invest. Dermatol. 75 (1980) 44-45
25. He Y., Zhang J., Mi Z., Robbins P., and Falo Jr. L.D. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J. Immunol. 174 (2005) 3808-3817
26. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., Davey G.M., Wilson N.S., Carbone F.R., and Villadangos J.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199 (2004) 9-26
27. Humlova Z., Vokurka M., Esteban M., and Melkova Z. Vaccinia virus induces apoptosis of infected macrophages. J. Gen. Virol. 83 (2002) 2821-2832
28. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., and Jenkins M.K. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 (2003) 47-57
29. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351 (2004) 2295-2301
30. Kissenpfennig A., Henri S., Dubois B., Laplace-Builhe C., Perrin P., Romani N., Tripp C.H., Douillard P., Leserman L., Kaiserlian D., et al. Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005) 643-654
31. Kurts C., Cannarile M., Klebba I., and Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166 (2001) 1439-1442
32. La Montagne J.R., and Fauci A.S. Intradermal influenza vaccination-can less be more?. N. Engl. J. Med. 351 (2004) 2330-2332
33. Larrengina A.T., and Falo L.D. Changing paradigms in cutaneous immunology: adapting with dendritic cells. J. Invest. Dermatol. 124 (2005) 1-12
34. Larsson M., Fonteneau J.F., Somersan S., Sanders C., Bickham K., Thomas E.K., Mahnke K., and Bhardwaj N. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 31 (2001) 3432-3442
35. Larsson M., Beignon A.S., and Bhardwaj N. DC-virus interplay: a double edged sword. Semin. Immunol. 16 (2004) 147-161
36. Liu M., Acres B., Balloul J.M., Bizouarne N., Paul S., Slos P., and Squiban P. Gene-based vaccines and immunotherapeutics. Proc. Natl. Acad. Sci. USA 101 Suppl 2 (2004) 14567-14571
37. Mayerova D., Parke E.A., Bursch L.S., Odumade O.A., and Hogquist K.A. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21 (2004) 391-400
38. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., Melief C.J., Ildstad S.T., Kast W.M., Deleo A.B., et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1 (1995) 1297-1302
39. Mempel T.R., Henrickson S.E., and Von Andrian U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427 (2004) 154-159
40. Moore A.C., and Hill A.V. Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol. Rev. 199 (2004) 126-143
41. Moron G., Rueda P., Casal I., and Leclerc C. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J. Exp. Med. 195 (2002) 1233-1245
42. Naik S., Vremec D., Wu L., O'Keeffe M., and Shortman K. CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha-dendritic cell subset. Blood 102 (2003) 601-604
43. Nicolo C., Tomassini B., Rippo M.R., and Testi R. UVB-induced apoptosis of human dendritic cells: contribution by caspase-dependent and caspase-independent pathways. Blood 97 (2001) 1803-1808
44. Norbury C.C., Malide D., Gibbs J.S., Bennink J.R., and Yewdell J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat. Immunol. 3 (2002) 265-271
45. Paglia P., Chiodoni C., Rodolfo M., and Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183 (1996) 317-322
46. Palmowski M.J., Lopes L., Ikeda Y., Salio M., Cerundolo V., and Collins M.K. Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. J. Immunol. 172 (2004) 1582-1587
47. Porgador A., Irvine K.R., Iwasaki A., Barber B.H., Restifo N.P., and Germain R.N. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188 (1998) 1075-1082
48. Racanelli V., Behrens S.E., Aliberti J., and Rehermann B. Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. Immunity 20 (2004) 47-58
49. Rosenberg S.A., Zhai Y., Yang J.C., Schwartzentruber D.J., Hwu P., Marincola F.M., Topalian S.L., Restifo N.P., Seipp C.A., Einhorn J.H., et al. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J. Natl. Cancer Inst. 90 (1998) 1894-1900
50. Sasaki S., Takeshita F., Xin K.Q., Ishii N., and Okuda K. Adjuvant formulations and delivery systems for DNA vaccines. Methods 31 (2003) 243-254
51. Serbina N.V., and Pamer E.G. Immunology. Giving credit where credit is due. Science 301 (2003) 1856-1857
52. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
53. Sixt M., Kanazawa N., Selg M., Samson T., Roos G., Reinhardt D.P., Pabst R., Lutz M.B., and Sorokin L. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22 (2005) 19-29
54. Smith C.M., Belz G.T., Wilson N.S., Villadangos J.A., Shortman K., Carbone F.R., and Heath W.R. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170 (2003) 4437-4440
55. Sporri R., and Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6 (2005) 163-170
56. Stingl G., Wolff-Schreiner E.C., Pichler W.J., Gschnait F., Knapp W., and Wolff K. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268 (1977) 245-246
57. Stingl G., Katz S.I., Green I., and Shevach E.M. The functional role of Langerhans cells. J. Invest. Dermatol. 74 (1980) 315-318
58. Stingl G., Tamaki K., and Katz S.I. Origin and function of epidermal Langerhans cells. Immunol. Rev. 53 (1980) 149-174
59. Stock A.T., Mueller S.N., van Lint A.L., Heath W.R., and Carbone F.R. Cutting edge: prolonged antigen presentation after herpes simplex virus-1 skin infection. J. Immunol. 173 (2004) 2241-2244
60. Stoll S., Delon J., Brotz T.M., and Germain R.N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296 (2002) 1873-1876
61. Valladeau J., and Saeland S. Cutaneous dendritic cells. Semin. Immunol. 17 (2005) 273-283
62. Yewdell J.W., and Haeryfar S.M. Understanding presentation of viral antigens to CD8(+) T-cells in vivo: the key to rationale vaccine design. Annu. Rev. Immunol. 23 (2005) 651-682
63. Young J.W., and Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183 (1996) 7-11
64. Zhang M., Ishii K., Hisaeda H., Murata S., Chiba T., Tanaka K., Li Y., Obata C., Furue M., and Himeno K. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein. Immunology 112 (2004) 567-574